GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Cyclically Adjusted PB Ratio

Embla Medical hf (OCSE:EMBLA) Cyclically Adjusted PB Ratio : 2.68 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Cyclically Adjusted PB Ratio?

As of today (2024-05-26), Embla Medical hf's current share price is kr28.50. Embla Medical hf's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr10.63. Embla Medical hf's Cyclically Adjusted PB Ratio for today is 2.68.

The historical rank and industry rank for Embla Medical hf's Cyclically Adjusted PB Ratio or its related term are showing as below:

OCSE:EMBLA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.58   Med: 5.04   Max: 8.12
Current: 2.68

During the past years, Embla Medical hf's highest Cyclically Adjusted PB Ratio was 8.12. The lowest was 2.58. And the median was 5.04.

OCSE:EMBLA's Cyclically Adjusted PB Ratio is ranked worse than
60.08% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs OCSE:EMBLA: 2.68

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Embla Medical hf's adjusted book value per share data for the three months ended in Mar. 2024 was kr11.755. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr10.63 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Embla Medical hf Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Embla Medical hf's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Cyclically Adjusted PB Ratio Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.63 6.54 5.21 3.63 2.66

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.23 3.24 2.82 2.66 3.15

Competitive Comparison of Embla Medical hf's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted PB Ratio falls into.



Embla Medical hf Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Embla Medical hf's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=28.50/10.63
=2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Embla Medical hf's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.755/144.9095*144.9095
=11.755

Current CPI (Mar. 2024) = 144.9095.

Embla Medical hf Quarterly Data

Book Value per Share CPI Adj_Book
201406 5.641 98.777 8.276
201409 5.962 98.734 8.750
201412 6.024 98.669 8.847
201503 6.546 99.612 9.523
201506 6.722 100.289 9.713
201509 6.863 100.607 9.885
201512 7.135 100.657 10.272
201603 7.054 101.115 10.109
201606 6.868 101.923 9.765
201609 7.048 102.457 9.968
201612 7.525 102.562 10.632
201703 7.132 102.768 10.057
201706 7.206 103.496 10.089
201709 6.998 103.871 9.763
201712 7.344 104.481 10.186
201803 7.035 105.600 9.654
201806 7.478 106.206 10.203
201809 7.671 106.727 10.415
201812 8.264 108.388 11.049
201903 8.244 108.702 10.990
201906 8.565 109.758 11.308
201909 8.816 109.922 11.622
201912 8.991 110.588 11.781
202003 8.663 111.019 11.308
202006 8.307 112.667 10.684
202009 8.251 113.772 10.509
202012 8.295 114.542 10.494
202103 8.567 115.833 10.717
202106 8.765 117.451 10.814
202109 9.098 118.723 11.105
202112 9.688 120.398 11.660
202203 10.029 123.555 11.762
202206 10.297 127.809 11.675
202209 10.768 129.810 12.021
202212 10.622 131.901 11.670
202303 10.720 135.674 11.450
202306 10.843 139.150 11.292
202309 11.220 140.147 11.601
202312 11.414 142.125 11.638
202403 11.755 144.910 11.755

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Embla Medical hf  (OCSE:EMBLA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Embla Medical hf Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines